Dirk Jan van Veldhuisen Selected Research

Dirk Jan van Veldhuisen Research Topics

3	Heart Failure 04/2022 - 04/2004
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Myocardial Infarction 01/2020 - 01/2015
1	Anemia 04/2022
1	Systolic Heart Failure 04/2022
1	Iron Deficiencies 08/2020
1	Dyspnea (Shortness of Breath) 08/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	ST Elevation Myocardial Infarction 01/2015
1	Pulmonary Hypertension 01/2009
1	Fibrosis (Cirrhosis) 01/2009
1	Cystic Fibrosis (Mucoviscidosis) 01/2009
1	Clinical Deterioration 01/2009
1	Familial Primary Pulmonary Hypertension 01/2009
1	Congenital Heart Defects (Congenital Heart Defect) 01/2009
1	Ventricular Dysfunction 01/2008
1	Peripheral Arterial Disease 01/2008
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2007

2	pro-brain natriuretic peptide (1-76)IBA 01/2018 - 01/2008
1	Growth Differentiation Factor 15IBA 04/2022
1	CytokinesIBA 04/2022
1	IronIBA 04/2022
1	Ferritins (Ferritin)IBA 04/2022
1	Darbepoetin alfa (Aranesp)FDA Link 04/2022
1	SeleniumIBA 08/2020
1	MicronutrientsIBA 08/2020
1	Serum AlbuminIBA 08/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 01/2018
1	Natriuretic PeptidesIBA 01/2018
1	Metformin (Glucophage)FDA LinkGeneric 01/2015
1	CreatinineIBA 01/2015
1	Lamin Type A (Lamin A)IBA 12/2007
1	Tumor Necrosis Factor InhibitorsIBA 04/2004
1	Etanercept (Enbrel)FDA Link 04/2004

2	Therapeutics 01/2020 - 04/2004
1	Percutaneous Coronary Intervention 01/2015
1	Heart-Lung Transplantation 01/2009
1	Drug Therapy (Chemotherapy) 01/2009
1	Transplantation 01/2009
1	Surgical Amputation (Amputations) 01/2008